Backround: The present study aimed to determine the frequency of spinal metastases, to evaluate the features of spinal metastases, and to reveal clues to shed light on the origin of spinal metastases with unknown primary.

Methods: The data of patients who were followed up with the diagnosis of cancer in Istanbul Oncology Hospital between 2017 and 2019 were analyzed retrospectively. A total of 156 patients with spinal metastases and without visceral metastases were included in the study by applying inclusion and exclusion criteria. Clinical data, pathological diagnostic reports, and positron emission tomography-computed tomography results of 156 patients were evaluated. The groups were evaluated in terms of age, gender, number of spinal metastases (single focus, multiple focus), and localization of spinal metastasis. The spinal localization evaluation included both the main anatomical localizations and a detailed evaluation of each spine.

Results: The most common metastasis region was the thoracic spine in respiratory system cancers (28.38%), the thoracic + lumbar spine in breast (42.42%), prostate (50.00%), and gynecologic (40.00%) cancers, and the lumbar spine in gastrointestinal (37.50%) and urinary (30.00%) tract cancers ( = .313). C5 spinal metastasis percentages were significantly higher in breast and gastrointestinal tract cancers than the others ( = .042). T5 spinal metastasis percentage was significantly higher in gynecologic tumors than in the other cancers ( = .002). T10 spinal metastasis percentages were significantly higher in prostate and gynecologic tumors than the others ( = .016). L1 spinal metastasis percentage was significantly higher in breast tumors ( = .009). L2 spinal metastasis percentages were significantly higher in breast, prostate, and gynecologic tumors ( = .011). L4 spinal metastasis percentages were significantly higher in breast and prostate tumors ( = .041). L5 spinal metastasis percentage was significantly higher in prostate tumors ( = .029) than the other cancers.

Conclusions: It was observed that primary cancers were often prone to metastasis to nearby spine. The results obtained by detailed examination of spinal metastases may provide a clinical benefit by providing clues in investigation of primary unknown cancers.

Level Of Evidence: 3.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7931703PMC
http://dx.doi.org/10.14444/8016DOI Listing

Publication Analysis

Top Keywords

spinal metastasis
32
spinal metastases
28
metastasis percentages
16
percentages higher
16
higher breast
16
spinal
15
metastasis percentage
12
percentage higher
12
gynecologic tumors
12
metastasis
10

Similar Publications

Background: Sigmoid colon cancer with spinal metastases is rare in distant metastasis. In addition, the prognosis of colon cancer patients with spinal metastases is extremely poor. In order to find effective therapeutic agents, we need to know the biological characteristics of such patients from related models.

View Article and Find Full Text PDF

Study Design: A retrospective study.

Purpose: This study aimed to determine the impact of increased Hounsfield unit (HU) values for metastatic spinal lesions measured via computed tomography on the overall survival of patients with non-small-cell lung cancer (NSCLC) and identify factors associated with increased HU values in metastatic spinal lesions.

Overview Of Literature: Previous studies have underscored the utility of the HU as a marker of treatment response in metastatic bone lesions.

View Article and Find Full Text PDF

Gastric cancer is described as a malignancy occurring in the region between the gastroesophageal junction and the pylorus. According to the histology, majority of gastric cancers are classified as adenocarcinomas. The prevalence of bone metastasis in the general population is 2-3%.

View Article and Find Full Text PDF

Background: Metastatic spine tumor surgery (MSTS) is often complex and extensive leading to significant blood loss. Allogeneic blood transfusion (ABT) is the mainstay of blood replenishment but with immune-mediated postoperative complications. Alternative blood management techniques (salvaged blood transfusion [SBT]) allow us to overcome such complications.

View Article and Find Full Text PDF

Activation of sphingosine-1-phosphate receptor 2 (S1PR2) upregulates dihydropyrimidine dehydrogenase (DPD) expression in colon cancer cells.

J Adv Res

January 2025

Pharmacology, School of Basic Medical Sciences, Capital Medical University, Beijing, China; Joint Laboratory for Research & Treatment of Spinal Cord Injury in Spinal Deformity, Capital Medical University, Beijing, China. Electronic address:

Introduction: Dihydropyrimidine dehydrogenase (DPD) is a major determinant of cancer 5-fluorouracyl (5-FU) resistance via its direct degradation. However, the mechanisms of tumoral DPD upregulation have not been fully understood.

Objectives: This study aimed to explore the role of S1PR2 in the regulation of tumoral DPD expression, identifying S1PR2 as the potential target for reversing 5-FU resistance.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!